Preliminary Results of a Trial of Atabecestat in Preclinical Alzheimer's Disease

被引:162
作者
Henley, David [1 ]
Raghavan, Nandini [1 ]
Sperling, Reisa [2 ]
Aisen, Paul
Raman, Rema
Romano, Gary [3 ]
机构
[1] Janssen Res & Dev, Pennington, NJ 08540 USA
[2] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[3] Janssen Res & Dev, Titusville, NJ USA
关键词
D O I
10.1056/NEJMc1813435
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A preliminary analysis of a trial involving participants with brain amyloid deposition who are at risk for dementia due to Alzheimer's disease showed no benefit of a beta-secretase enzyme inhibitor over placebo and a potential signal of worse cognitive test scores over 3 and 6 months.
引用
收藏
页码:1483 / 1485
页数:3
相关论文
共 5 条
[1]   The Preclinical Alzheimer Cognitive Composite Measuring Amyloid-Related Decline [J].
Donohue, Michael C. ;
Sperling, Reisa A. ;
Salmon, David P. ;
Rentz, Dorene M. ;
Raman, Rema ;
Thomas, Ronald G. ;
Weiner, Michael ;
Aisen, Paul S. .
JAMA NEUROLOGY, 2014, 71 (08) :961-970
[2]   Randomized Trial of Verubecestat for Prodromal Alzheimer's Disease [J].
Egan, Michael F. ;
Kost, James ;
Voss, Tiffini ;
Mukai, Yuki ;
Aisen, Paul S. ;
Cummings, Jeffrey L. ;
Tariot, Pierre N. ;
Vellas, Bruno ;
van Dyck, Christopher H. ;
Boada, Merce ;
Zhang, Ying ;
Li, Wen ;
Furtek, Christine ;
Mahoney, Erin ;
Mozley, Lyn Harper ;
Mo, Yi ;
Sur, Cyrille ;
Michelson, David .
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (15) :1408-1420
[3]  
Janssen Global Services, 2018, UPD JANSS BACE INH P
[4]   The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): Utility in Detection and Characterization of Mild Cognitive Impairment due to Alzheimers Disease [J].
Karantzoulis, Stella ;
Novitski, Julia ;
Gold, Michael ;
Randolph, Christopher .
ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2013, 28 (08) :837-844
[5]  
The Lancet Haematology, 2018, J PREV ALZHEIMERS DI, V5, pe127